Birgitte Booij

Birgitte Booij is an accomplished scientific leader currently serving as the Chief Scientific Officer at SpinChip Diagnostics ASA since November 2024. With extensive experience in the biomedical field, Booij previously held the position of Senior Portfolio Manager at the Coalition for Epidemic Preparedness Innovations (CEPI) from May 2021 to November 2024 and contributed as a Board Member at Pre Diagnostics AS from February 2019 to July 2023. Booij's career includes significant roles such as Vice President of Business Development at SpinChip Diagnostics AS and Co-founder and Advisor at Pre Diagnostics AS. Additional expertise was gained through positions at Oslo University Hospital, Clavis Pharma ASA, DiaGenic ASA, and Axis-Shield ASA, along with a strong academic foundation from the University of Cambridge, where Booij earned a Ph.D. in Biotechnology. Booij also holds a Master of Science degree in Biochemistry from the University of Groningen and has completed further education at BI Norwegian Business School.